| Title: | Atypical COQ2-related retinopathy in identical twins with nephropathy mimicking intermediate uveitis |
|---|
| Authors: | ID Gavrič, Ana Uršula (Author)
ID Volk, Marija (Author)
ID Kojc, Nika (Author)
ID Osredkar, Damjan (Author)
ID Meglič, Andrej (Author)
ID Šuštar Habjan, Maja (Author)
ID Kiraly, Peter (Author)
ID Jaki Mekjavić, Polona (Author) |
|---|
| Files: |  PDF - Presentation file, download (11,48 MB)
MD5: 3B6525301B09532F423A6CA44D442154
 URL - Source URL, visit https://www.tandfonline.com/doi/full/10.1080/09273948.2026.2679855
|
|---|
| Language: | English |
|---|
| Typology: | 1.03 - Other scientific articles |
|---|
| Organization: |  UKC LJ - Ljubljana University Medical Centre
|
|---|
| Abstract: | Purpose: To describe an atypical presentation of COQ2-related retinopathy in identical twins withnephropathy, mimicking intermediate uveitis with cystoid macular oedema (CMO).Methods: Retrospective case report.Results: A 33-year-old man presented with bilateral vision worsening and suspected intermediate uveitis.Examination revealed vitreous cells, CMO, retinal microangiopathy, and severely abnormal electrooculo-graphy (EOG) with only borderline full-field electroretinography (ERG) changes. CMO worsened withtopical corticosteroids but improved bilaterally after a single unilateral intravitreal bevacizumab injection,suggesting a systemic therapeutic effect. His identical twin exhibited very similar retinal and systemicfindings. Whole-exome sequencing identified a homozygous likely pathogenic COQ2 variant (c.683A >G), confirming primary coenzyme Q10 (CoQ10) deficiency type 1. Both twins also had nephropathyconsistent with focal segmental glomerulosclerosis (FSGS) but no neurological involvement.Conclusions: This report expands the phenotypic spectrum of COQ2-related retinopathy, characterizedby retinal microangiopathy, CMO, and primary retinal pigment epithelium (RPE) dysfunction with pre-served rod function, in contrast to the typical retinitis pigmentosa–like phenotype. Recognition of thispresentation is critical, as early CoQ10 supplementation may stabilize disease progression and preventsystemic complications. Genetic testing should be considered in young patients with CMO resemblingintermediate uveitis, particularly when associated with nephropathy. |
|---|
| Keywords: | COQ2-related retinopathy, uveitis, rare disease |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Year of publishing: | 2026 |
|---|
| Number of pages: | str. 1200-1205 |
|---|
| Numbering: | Vol. 34, issue 5 |
|---|
| PID: | 20.500.12556/DiRROS-31914  |
|---|
| UDC: | 617.7 |
|---|
| ISSN on article: | 1744-5078 |
|---|
| DOI: | 10.1080/09273948.2026.2679855 |
|---|
| COBISS.SI-ID: | 279820803 |
|---|
| Note: | Nasl. z nasl. zaslona;
Opis vira z dne 29. 5. 2026;
|
|---|
| Publication date in DiRROS: | 18.08.2026 |
|---|
| Views: | 42 |
|---|
| Downloads: | 31 |
|---|
| Metadata: |    |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
